1. A phase 2a trial investigating ninerafaxstat – a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE). (3rd October 2022) Authors: Hundertmark, M; Siu, A G; Matthews, V; Lewis, A J; Grist, J T; Patel, J; Chamberlin, P; Sarwar, R; Yavari, A; Frenneaux, M P; Valkovic, L; Miller, J J J J; Neubauer, S; Tyler, D J; Rider, O J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗